银诺医药-B二零二五年中期报告
廣 州 銀 諾 醫 藥 集 團 股 份 有 限 公 司Guangzhou Innogen Pharmaceutical Group Co., Ltd. 股份代號 : 2591（於中華人民共和國成立的股份有限公司） 2 4 5 16 27 28 29 30 32 46 WANG QINGHUA HO KYUNG SHIK 2H409 2H409 24840 WANG QINGHUA 88173121209 WANG QINGHUA WANG QINGHUA 140 158F408 97927 H 1617 2591 www.innogenpharm.com 2014(MASH)α202512(T2D)α 1.201912αIαIαT2DMASH2.αα20256αT2DBLABLA2025BLABLAα αT2D αGLP-1αT2DBLA20239(NMPA)2025120252T2Dα αα20256αT2DBLABLA2025BLABLAα α 20253αIIb/III2026 20258αII200 αMASH 20233FDAαMASHIIaIND20253NMPAαMASHIND2026MASHIIa α (AD)YN014 YN014IND2026FDAYN014IND YN014 1YN401 YN401IND20252026IND YN401 MASHYN209 IND2026IND YN209 YN209 T2DYN203 YN203IND2026IND YN203 YN202 YN202IND2026IND YN202 20252T2Dα202563056.4α 20256306.0 20252T2Dα2025630αα2025630α 202563050.589.4% (i)(ii) 202463012.120256305.2(i)20246304.2(ii)2025630 (i)(ii)(iii)(iv)(v) 202463051.9202563099.1(i)18.1ααIIb/III(ii)29.5αCDMOαIIb/IIICRO (i)(ii)(iii)(iv) 202463030.1202563031.6 2024202563044.0 2024630202563044.020252α (i)(ii)(iii) 20246304.520256303.120246304.520256301.61.3 (i)(ii)20246300.920256300.420246 20241231701.02025630615.420241231138.32025630241.7CDMOCDMO 202563027%2024123115% 202412319.9202563040.02.11%3.00%202563016.92025630 630 202563028.2 2025630 202563010545.728.62025630843945 2025815HH18.6836,556,400H 2025630 2025α2(T2D)α α20256αT2DBLABLA2025BLABLA 20253αIIb/III202620258αII200 2025α 36,556,400H2025815634.7 H2025815571 C1 H C.2.1 H 13.51B(1) 2025630HXV XV352 1.L2.(i)36,533,979(ii) H420,285,3703.456,819,3494.(i)5,792,02023,168,082H(ii)6,554,92926,219,717H(iii)728,0002,912,000H2,550,04410,200,178H5.2020121(i)(ii)5,450,72021,802,880H XV 2025630HXV 3365% 1.L2.(i)36,533,979(ii)420,285,370H3.456,819,3494.2020121(i)(ii)24,868,90499,475,622H5.(i)5,792,02023,168,082H(ii)6,554,92926,219,717H(iii)728,0002,912,000H6.SEA CHINA FUND50.26%SEA CHINA FUNDKIPKIS83.67%KISKIH071050SEA CHINA FUNDKIS26,556,4447.KIPKIPKIH071050KIPKIH(i)26,556,444H(ii)7,587,556H(iii)7,587,556H8.Cowin China Fund IICowin Capital Investment IICowin CapitalInvestment IICowin Capital Investment70.00%Cowin Capital InvestmentCowin CapitalInvestment IIICowin Capita Investment III50.00%50.00%Cowin Capital Investment IICowin Capital InvestmentCowin Capital Investment IIICowin China Fund II26,556,444 9.83279335.01%55.00%45.00%(i)11,381,333H(ii)6,033,354H 10.Palace InvestmentsPavCap Fund IPavCap Fund IPavCap I Feeder No. 1LPPavCap I Feeder No. 1 LPPavilion Capital GP Pte. Ltd.Pavilion Capital GP Pte. Ltd.Linden Investments Pte. Ltd.Linden Investments Pte. Ltd.Fullerton Fund Investments Pte. Ltd.Fullerton Fund Investments Pte. Ltd.TemasekPavCap Fund IPavCap I Feeder No. 1 LPPavilion Capital GP Pte. Ltd.Linden Investments Pte. Ltd.Fullerton Fund Investments Pte. Ltd.TemasekPalaceInvestments25,344,931H 11.91.00%91.55%22,594,783H 12.99.98%22,594,783H 13.3908601995 39.84%50.00%50.00% 2,353,008 H5,490,353HH1.31% 14.0165 50.00%39.00%41.76%2,413,342 H2,413,342HH0.57% 336 8.0825% 2025926 3.21 2025630 H8.10 WANG QINGHUA 2025829 2025630 2025630 2025630 2025630 2025630 2025630 1. 20141252H409 H2025815 2.1 202563034202587202320241231 2.2 20241231 21 21 2025630 3. 8 4. 2025630 4. 2025630 6. 7. 2025630 8. 2024202563025% 9. 20256302024630 10. 11. 20256304,160,00020246301,561,000 202563020246304,451,000 2025630 2025630 12. 510 (a) (b) 2025630 12. (c) 2025630 14. 2025630 17. 2025630 19. 1 2.11%3.00% 2025630 20. (a)B+B+2024250,000,00022,594,78322,594,783227,405,217 2025630 21. 202332865,375,00032,775,00028,960,0003,640,0001.00 2023202420252026123125%25%25%25%2023920241,940,00050%2025123150%20261231 202411 202420256304,764,0008,718,000 2023202412319.4611.06 2025630 22. 202563020241231 23. (a) 20242025630 (b) 24. 2025630 24. 20256302024630 25. 2 0 2 581 5HH1 8 . 6 836,556,400H 26. 2025829 H1.00H2025815HC3 20258720256301.00H1.00%
